Finasteride Tablets — Class III drug recall D-0453-2017
Terminated recall by Hetero Drugs Ltd. - Unit 1, reported 2017-02-08, distributed in NJ. Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
| Recall number | D-0453-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hetero Drugs Ltd. - Unit 1, Medak District, N/A, India |
| Recall initiated | 2016-12-29 |
| Classified | 2017-01-31 |
| Reported by FDA | 2017-02-08 |
| Terminated | 2017-07-11 |
| Distributed | NJ |
| Quantity | 20,412 units |
| NDC | 31722-0525, 31722-0525-01, 31722-0525-05, 31722-0525-10, 31722-0525-30, 31722-0525-90 |
| Lot numbers | FIN16002 |
| Expiration dates | 2018-03 |
Product
Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90
Reason for recall
Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0453-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.